HCA Healthcare, Inc. (HCA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
HCA Healthcare, Inc. (HCA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Fiscal Year: January - December
HCA Healthcare, Inc. (HCA), listed on the NYSE, has a market capitalization of $119.18B. As of Mar 14, 2026, the stock is trading at $532.97 per share@else an unavailable price , offering investors a clear view of its current market value. HCA Healthcare, Inc. is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 18.81, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. HCA Healthcare, Inc. also offers a dividend yield of 0.59%, making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that HCA Healthcare, Inc. (HCA) may be overvalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for HCA Healthcare, Inc. is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for HCA Healthcare, Inc., Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for HCA Healthcare, Inc. is 15.49, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, HCA Healthcare, Inc. (HCA) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether HCA Healthcare, Inc. (HCA) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be overvalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of HCA Healthcare, Inc. (HCA) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of HCA Healthcare, Inc.. To access the full SS Score, consider upgrading your subscription.
HCA Healthcare, Inc. is a significant player in the industry sector, with a market capitalization of $119.18B and a competitive P/E ratio of 18.81. Investors should compare these metrics with industry peers to gauge whether HCA Healthcare, Inc. is outperforming or underperforming within its sector.
HCA Healthcare, Inc. (HCA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
HCA Healthcare, Inc. (HCA) Presents at Leerink Global Healthcare Conference 2026 Transcript
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that 92 of its hospitals achieved the 2026 Patient Safety Excellen...
HCA Healthcare, Inc. (HCA) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
HCA Healthcare, Inc. (HCA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences: March 3, 2026 at 10:30am ET at the TD Cowen Health Care Conference ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has been named on Fortune's 2026 World's Most Admired Comp...
The Global Real Assets Fund A Shares (without sales charge*) posted a return of 2.75% in fourth quarter 2025. Leading contributors in the First Eagle Global Real Assets Fund this quarter included Sams...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that three of its hospitals were named among America's 50 Best Hos...
HCA Healthcare Inc. (NYSE: HCA) released mixed fourth-quarter 2025 financial results on Tuesday.
HCA Healthcare Inc. (NYSE: HCA) released mixed fourth-quarter 2025 financial results on Tuesday.
HCA Healthcare, Inc. (HCA) Q4 2025 Earnings Call Transcript
HCA Healthcare has delivered robust earnings, aggressive buybacks, and margin expansion, driving shares up over 40% in the past year. Q4 results and 2026 guidance were strong, but margin benefits may ...
HCA Healthcare Inc. (NYSE: HCA), one of the nation's largest hospital operators, released mixed fourth-quarter 2025 financial results on Tuesday.
HCA Healthcare on Tuesday forecast its profit for 2026 above Wall Street estimates as it expects lower costs and robust demand for its medical care services.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2025. Key fourth quarter metrics (all perc...
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Erica Rossitto, MBA/HCM, BSN, RN, NEA-BC, has been promoted t...
CANTON, Mass.--(BUSINESS WIRE)--MEDITECH has announced the go-live of the first large-scale wave of its enterprise-wide MEDITECH Expanse EHR implementations at HCA Healthcare, one of the nation's lead...
As the healthcare sector grapples with ongoing regulatory shifts and economic pressures, hospitals find themselves navigating a challenging landscape shaped by policy changes and financial constraints...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 4Q 2025 Earnings Call When: Tuesday, January 27, 2026 at 9:00 AM Cen...
CANTON, Mass.--(BUSINESS WIRE)--Leading private healthcare provider, HCA Healthcare UK (HCA UK), is now live with MEDITECH Expanse across its 11 acute facilities and dozens of outpatient locations, en...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Virginia Tenpenny has been named vice president of community ...
I track a custom universe of 50 high-quality dividend growth stocks to identify timely, attractive investment opportunities based on valuation and forward return potential. 28 of these stocks currentl...
HCA Healthcare remains undervalued despite strong YTD outperformance, supported by robust profit and cash flow growth. HCA is positioned to benefit from an aging U.S. population, expanding hospital ca...
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2026 | 7.51B | Analyst x3 | |
| 2027 | 7.83B | 4.30% | Analyst x3 |
| 2028 | 7.41B | -5.40% | Analyst x1 |
| 2029 | 7.81B | 5.45% | Analyst x1 |
| 2030 | 8.27B | 5.78% | Analyst x1 |
| 2031 | 8.42B | 1.91% | Est @1.9% |
| 2032 | 8.60B | 2.10% | Est @2.1% |
| 2033 | 8.79B | 2.24% | Est @2.2% |
| 2034 | 8.98B | 2.18% | Est @2.2% |
| 2035 | 9.19B | 2.24% | Est @2.2% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2024A | 5.64B | 1.00 | 5.64B |
| 2025A | 7.69B | 1.00 | 7.69B |
| 2026E | 7.51B | 1.09 | 6.90B |
| 2027E | 7.83B | 1.18 | 6.62B |
| 2028E | 7.41B | 1.29 | 5.75B |
| 2029E | 7.81B | 1.40 | 5.58B |
| 2030E | 8.27B | 1.52 | 5.42B |
| 2031E | 8.42B | 1.66 | 5.08B |
| 2032E | 8.60B | 1.80 | 4.77B |
| 2033E | 8.79B | 1.96 | 4.48B |
| 2034E | 8.98B | 2.14 | 4.21B |
| 2035E | 9.19B | 2.32 | 3.95B |
| Terminal | 149.45B | 2.32 | 64.30B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.